Vice President, Head of Global Research Strategy, ViiV Healthcare
Max Lataillade is responsible for global research and development strategy for the HIV pipeline at ViiV Healthcare, the only company 100% dedicated to HIV. He oversees end-to-end R&D activities for all novel HIV pipeline programs designed to address key unmet medical needs for people...
Read More →